Skip to main content

Protein Discovery, New Objective Ink Co-Marketing Deal

NEW YORK (GenomeWeb News) – Protein Discovery and New Objective will co-market each other's proteomics technologies and will develop new products under a new agreement, Protein Discovery said today.

The marketing agreement covers Protein Discovery's GelFree 8100 Fractionation System and New Objectives' PicoFrit nanobore chromatography columns and Digital PicoView nanospray sources.

Protein Discovery said that the combined technologies will give researchers top-down protein analysis with an integrated, standardized workflow for mass spectrometry projects.

The companies will co-market their products through industry publications and through trade shows, and will work together to develop new products aimed at improving the data quality and throughput of intact protein analysis.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.